NEW YORK and LONDON, November 11th, 2016
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will attend and host meetings at two upcoming conferences.
• Jefferies 2016 London Healthcare Conference, November 16-17, 2016 in London, UK
• Oppenheimer Life Sciences Summit on Tuesday, November 29, 2016 in New York, NY
